SG11201502713QA - Compositions, structures and methods for neural regeneration - Google Patents
Compositions, structures and methods for neural regenerationInfo
- Publication number
- SG11201502713QA SG11201502713QA SG11201502713QA SG11201502713QA SG11201502713QA SG 11201502713Q A SG11201502713Q A SG 11201502713QA SG 11201502713Q A SG11201502713Q A SG 11201502713QA SG 11201502713Q A SG11201502713Q A SG 11201502713QA SG 11201502713Q A SG11201502713Q A SG 11201502713QA
- Authority
- SG
- Singapore
- Prior art keywords
- compositions
- structures
- methods
- neural regeneration
- neural
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
- A61L27/3633—Extracellular matrix [ECM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
- A61L27/3675—Nerve tissue, e.g. brain, spinal cord, nerves, dura mater
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3878—Nerve tissue, brain, spinal cord, nerves, dura mater
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/32—Materials or treatment for tissue regeneration for nerve reconstruction
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261711018P | 2012-10-08 | 2012-10-08 | |
PCT/US2013/060530 WO2014058586A1 (en) | 2012-10-08 | 2013-09-19 | Compositions, structures and methods for neural regeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201502713QA true SG11201502713QA (en) | 2015-05-28 |
Family
ID=50432837
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201502713QA SG11201502713QA (en) | 2012-10-08 | 2013-09-19 | Compositions, structures and methods for neural regeneration |
Country Status (11)
Country | Link |
---|---|
US (1) | US20140099352A1 (en) |
EP (1) | EP2914335A4 (en) |
JP (1) | JP2015533094A (en) |
KR (1) | KR20150068425A (en) |
CN (1) | CN104822414A (en) |
AU (1) | AU2013330360A1 (en) |
BR (1) | BR112015007860A2 (en) |
CA (1) | CA2887347A1 (en) |
IL (1) | IL238067A0 (en) |
SG (1) | SG11201502713QA (en) |
WO (1) | WO2014058586A1 (en) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11229789B2 (en) | 2013-05-30 | 2022-01-25 | Neurostim Oab, Inc. | Neuro activator with controller |
EP3441109A1 (en) | 2013-05-30 | 2019-02-13 | Graham H. Creasey | Flexible dermal patch for a topical nerve stimulator system |
US9238090B1 (en) | 2014-12-24 | 2016-01-19 | Fettech, Llc | Tissue-based compositions |
CN104548205B (en) * | 2014-12-29 | 2017-07-21 | 东莞颠覆产品设计有限公司 | A kind of animal sources Nerve Scaffold and preparation method thereof |
US11077301B2 (en) | 2015-02-21 | 2021-08-03 | NeurostimOAB, Inc. | Topical nerve stimulator and sensor for bladder control |
KR101871673B1 (en) * | 2016-07-29 | 2018-06-27 | 주식회사 파마리서치프로덕트 | Composition comprising nucleic acid and chitosan for repair of rotator cuff tear |
CN109310800B (en) * | 2016-07-29 | 2022-01-07 | 医药研究有限公司 | Composition for rotator cuff tear repair comprising nucleic acid and chitosan |
CN108114317A (en) * | 2016-11-28 | 2018-06-05 | 中国科学院遗传与发育生物学研究所 | The repairing of neural injury collagen as tissue engineering scaffold of compound umbilical cord mesenchymal stem cells |
KR101972450B1 (en) | 2017-04-21 | 2019-04-25 | 한국과학기술연구원 | Composition for preparing a biocompatible tissue, method preparing the same and method treating a disease requiring a vascularization |
CN107441557B (en) * | 2017-07-05 | 2020-07-17 | 北京大清生物技术股份有限公司 | Functional tissue engineering scaffold material and preparation method thereof |
WO2019036331A1 (en) * | 2017-08-15 | 2019-02-21 | The Children's Medical Center Corporation | Osteopontin as a treatment for neuronal lesions |
KR102562469B1 (en) | 2017-11-07 | 2023-08-01 | 뉴로스팀 오에이비, 인크. | Non-invasive nerve activator with adaptive circuitry |
KR102265640B1 (en) | 2019-03-19 | 2021-06-18 | 고려대학교 산학협력단 | Method for preparing of nerve conduit using bio-printing technology and the nerve conduit prepared by the same |
US20220213441A1 (en) * | 2019-05-16 | 2022-07-07 | The Chinese University Of Hong Kong | Extracellular matrix material and uses thereof |
EP3990100A4 (en) | 2019-06-26 | 2023-07-19 | Neurostim Technologies LLC | Non-invasive nerve activator with adaptive circuit |
KR20220115802A (en) | 2019-12-16 | 2022-08-18 | 뉴로스팀 테크놀로지스 엘엘씨 | Non-invasive neural activator with boost charge transfer function |
JP2024020670A (en) * | 2020-12-25 | 2024-02-15 | ニプロ株式会社 | Growth guide member and tissue regeneration device |
US20230338029A1 (en) * | 2022-04-05 | 2023-10-26 | Pioneer Neurotech Inc. | Nerve growth system |
CN115429937B (en) * | 2022-11-08 | 2023-04-28 | 圣至润合(北京)生物科技有限公司 | Soft tissue filling repair material and preparation method thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001233168A1 (en) * | 2000-01-31 | 2001-08-07 | Children's Medical Center Corporation | Neural regeneration conduit |
WO2005046457A2 (en) * | 2003-11-05 | 2005-05-26 | Texas Scottish Rite Hospital For Children | A biomimetic biosynthetic nerve implant |
US8932620B2 (en) * | 2005-06-17 | 2015-01-13 | Drexel University | Three-dimensional scaffolds for tissue engineering made by processing complex extracts of natural extracellular matrices |
EP2240090B1 (en) * | 2008-01-25 | 2019-06-19 | The Johns Hopkins University | Biodegradable nerve guides |
KR20120033299A (en) * | 2009-02-18 | 2012-04-06 | 코매트릭스 카디오바스컬라 인코포레이티드 | Compositions and methods for preventing cardiac arrhythmia |
EP3888714A1 (en) * | 2010-07-31 | 2021-10-06 | Cook Medical Technologies LLC | Collagenous tissue pocket for an implantable medical device, and manufacturing method therefor |
-
2013
- 2013-09-19 CN CN201380062856.5A patent/CN104822414A/en active Pending
- 2013-09-19 EP EP13846017.5A patent/EP2914335A4/en not_active Withdrawn
- 2013-09-19 SG SG11201502713QA patent/SG11201502713QA/en unknown
- 2013-09-19 CA CA2887347A patent/CA2887347A1/en not_active Abandoned
- 2013-09-19 US US14/031,189 patent/US20140099352A1/en not_active Abandoned
- 2013-09-19 AU AU2013330360A patent/AU2013330360A1/en not_active Abandoned
- 2013-09-19 BR BR112015007860A patent/BR112015007860A2/en not_active IP Right Cessation
- 2013-09-19 JP JP2015535675A patent/JP2015533094A/en active Pending
- 2013-09-19 WO PCT/US2013/060530 patent/WO2014058586A1/en active Application Filing
- 2013-09-19 KR KR1020157011713A patent/KR20150068425A/en not_active Application Discontinuation
-
2015
- 2015-03-31 IL IL238067A patent/IL238067A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
BR112015007860A2 (en) | 2017-07-04 |
WO2014058586A1 (en) | 2014-04-17 |
CN104822414A (en) | 2015-08-05 |
AU2013330360A1 (en) | 2015-04-23 |
JP2015533094A (en) | 2015-11-19 |
IL238067A0 (en) | 2015-05-31 |
US20140099352A1 (en) | 2014-04-10 |
CA2887347A1 (en) | 2014-04-17 |
EP2914335A1 (en) | 2015-09-09 |
EP2914335A4 (en) | 2016-08-17 |
KR20150068425A (en) | 2015-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL238067A0 (en) | Compositions, structures and methods for neural regeneration | |
HK1250690A1 (en) | Methods | |
HK1214521A1 (en) | Compositions and methods for treating proteinopathies | |
HK1208363A1 (en) | New methods | |
HK1210913A1 (en) | Particles, methods and uses thereof | |
IL237068A (en) | 1,3-dioxanomorphides and 1,3-dioxanocodides | |
HK1212625A1 (en) | Anti-cxcl9, anti-cxcl10, anti-cxcl11, anti-cxcl13, anti-cxcr3 and anti-cxcr5 agents for inflammatory disorder -cxcl9-cxcl10-cxcl11-cxcl13-cxcr3 -cxcr5 | |
IL229262A0 (en) | Superstructure and methods for manufacturing the same | |
EP2847130A4 (en) | Compositions, methods, and systems for separating carbon-based nanostructures | |
GB2507760B (en) | Methods | |
EP2837627A4 (en) | Amidopyridine derivative, and use thereof | |
EP2813495A4 (en) | 2-arylbenzofuran-7-formamide compounds, preparation method and use thereof | |
PL2666562T3 (en) | Regeneration device | |
EP2880048A4 (en) | Method | |
GB201208874D0 (en) | Methods | |
EP2931324A4 (en) | Compositions and methods for tissue regeneration | |
GB201202198D0 (en) | Method | |
GB201204280D0 (en) | Methods | |
HK1209040A1 (en) | Methods for treating vestibulotoxicity | |
GB201315998D0 (en) | Catalyst regeneration | |
GB201208756D0 (en) | Methods | |
GB201203337D0 (en) | Method | |
GB201201332D0 (en) | Method | |
EP2639418A4 (en) | Exhaust-heating method | |
GB201218327D0 (en) | Eliminator |